GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MegaPro Biomedical Co Ltd (ROCO:6827) » Definitions » Sale Of Investment

MegaPro Biomedical Co (ROCO:6827) Sale Of Investment : NT$5.99 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MegaPro Biomedical Co Sale Of Investment?

MegaPro Biomedical Co's sale of investment for the six months ended in Dec. 2024 was NT$-16.08 Mil. It means MegaPro Biomedical Co gained NT$-16.08 Mil from selling investments. MegaPro Biomedical Co's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was NT$5.99 Mil.

Compared with last quarter (NT$22.07 Mil in Jun. 2024 ), MegaPro Biomedical Co gained less money from selling investments in Dec. 2024 (NT$-16.08 Mil).


MegaPro Biomedical Co Sale Of Investment Historical Data

The historical data trend for MegaPro Biomedical Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MegaPro Biomedical Co Sale Of Investment Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial 184.85 -66.90 70.67 54.87 5.99

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.17 - - 22.07 -16.08

MegaPro Biomedical Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$5.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MegaPro Biomedical Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of MegaPro Biomedical Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


MegaPro Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.

MegaPro Biomedical Co Headlines

No Headlines